Antibody induction after combined application of an adjuvanted recombinant FeLV vaccine and a multivalent modified live virus vaccine with a chlamydial component

The compatibility, safety and interaction on antibody induction of a combined vaccine application were assessed. Specific pathogen-free cats were vaccinated with either a modified live virus vaccine containing feline calici- (FCV), herpes- (FHV-1), parvovirus (FPV) and Chlamydophila felis (C. felis)...

Descripción completa

Detalles Bibliográficos
Autores principales: Brunner, Chantal, Kanellos, Theo, Meli, Marina L., Sutton, David J., Gisler, Ricarda, Gomes-Keller, Maria Alice, Hofmann-Lehmann, Regina, Lutz, Hans
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2006
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115673/
https://www.ncbi.nlm.nih.gov/pubmed/16343700
http://dx.doi.org/10.1016/j.vaccine.2005.10.030
_version_ 1783514147487481856
author Brunner, Chantal
Kanellos, Theo
Meli, Marina L.
Sutton, David J.
Gisler, Ricarda
Gomes-Keller, Maria Alice
Hofmann-Lehmann, Regina
Lutz, Hans
author_facet Brunner, Chantal
Kanellos, Theo
Meli, Marina L.
Sutton, David J.
Gisler, Ricarda
Gomes-Keller, Maria Alice
Hofmann-Lehmann, Regina
Lutz, Hans
author_sort Brunner, Chantal
collection PubMed
description The compatibility, safety and interaction on antibody induction of a combined vaccine application were assessed. Specific pathogen-free cats were vaccinated with either a modified live virus vaccine containing feline calici- (FCV), herpes- (FHV-1), parvovirus (FPV) and Chlamydophila felis (C. felis), an adjuvanted recombinant feline leukaemia virus (FeLV) vaccine or both vaccines in one syringe. After combined application, FeLV ELISA antibody titres were unaltered, However antibody production based on indirect immunofluorescence assay was remarkably enhanced for FCV and was at selected time points also enhanced for FHV-1 and C. felis but diminished for FPV. The use of these vaccines in combination was safe and will simplify vaccination schedules in veterinary practice.
format Online
Article
Text
id pubmed-7115673
institution National Center for Biotechnology Information
language English
publishDate 2006
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-71156732020-04-02 Antibody induction after combined application of an adjuvanted recombinant FeLV vaccine and a multivalent modified live virus vaccine with a chlamydial component Brunner, Chantal Kanellos, Theo Meli, Marina L. Sutton, David J. Gisler, Ricarda Gomes-Keller, Maria Alice Hofmann-Lehmann, Regina Lutz, Hans Vaccine Article The compatibility, safety and interaction on antibody induction of a combined vaccine application were assessed. Specific pathogen-free cats were vaccinated with either a modified live virus vaccine containing feline calici- (FCV), herpes- (FHV-1), parvovirus (FPV) and Chlamydophila felis (C. felis), an adjuvanted recombinant feline leukaemia virus (FeLV) vaccine or both vaccines in one syringe. After combined application, FeLV ELISA antibody titres were unaltered, However antibody production based on indirect immunofluorescence assay was remarkably enhanced for FCV and was at selected time points also enhanced for FHV-1 and C. felis but diminished for FPV. The use of these vaccines in combination was safe and will simplify vaccination schedules in veterinary practice. Elsevier Ltd. 2006-03-10 2005-11-15 /pmc/articles/PMC7115673/ /pubmed/16343700 http://dx.doi.org/10.1016/j.vaccine.2005.10.030 Text en Copyright © 2005 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Brunner, Chantal
Kanellos, Theo
Meli, Marina L.
Sutton, David J.
Gisler, Ricarda
Gomes-Keller, Maria Alice
Hofmann-Lehmann, Regina
Lutz, Hans
Antibody induction after combined application of an adjuvanted recombinant FeLV vaccine and a multivalent modified live virus vaccine with a chlamydial component
title Antibody induction after combined application of an adjuvanted recombinant FeLV vaccine and a multivalent modified live virus vaccine with a chlamydial component
title_full Antibody induction after combined application of an adjuvanted recombinant FeLV vaccine and a multivalent modified live virus vaccine with a chlamydial component
title_fullStr Antibody induction after combined application of an adjuvanted recombinant FeLV vaccine and a multivalent modified live virus vaccine with a chlamydial component
title_full_unstemmed Antibody induction after combined application of an adjuvanted recombinant FeLV vaccine and a multivalent modified live virus vaccine with a chlamydial component
title_short Antibody induction after combined application of an adjuvanted recombinant FeLV vaccine and a multivalent modified live virus vaccine with a chlamydial component
title_sort antibody induction after combined application of an adjuvanted recombinant felv vaccine and a multivalent modified live virus vaccine with a chlamydial component
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115673/
https://www.ncbi.nlm.nih.gov/pubmed/16343700
http://dx.doi.org/10.1016/j.vaccine.2005.10.030
work_keys_str_mv AT brunnerchantal antibodyinductionaftercombinedapplicationofanadjuvantedrecombinantfelvvaccineandamultivalentmodifiedlivevirusvaccinewithachlamydialcomponent
AT kanellostheo antibodyinductionaftercombinedapplicationofanadjuvantedrecombinantfelvvaccineandamultivalentmodifiedlivevirusvaccinewithachlamydialcomponent
AT melimarinal antibodyinductionaftercombinedapplicationofanadjuvantedrecombinantfelvvaccineandamultivalentmodifiedlivevirusvaccinewithachlamydialcomponent
AT suttondavidj antibodyinductionaftercombinedapplicationofanadjuvantedrecombinantfelvvaccineandamultivalentmodifiedlivevirusvaccinewithachlamydialcomponent
AT gislerricarda antibodyinductionaftercombinedapplicationofanadjuvantedrecombinantfelvvaccineandamultivalentmodifiedlivevirusvaccinewithachlamydialcomponent
AT gomeskellermariaalice antibodyinductionaftercombinedapplicationofanadjuvantedrecombinantfelvvaccineandamultivalentmodifiedlivevirusvaccinewithachlamydialcomponent
AT hofmannlehmannregina antibodyinductionaftercombinedapplicationofanadjuvantedrecombinantfelvvaccineandamultivalentmodifiedlivevirusvaccinewithachlamydialcomponent
AT lutzhans antibodyinductionaftercombinedapplicationofanadjuvantedrecombinantfelvvaccineandamultivalentmodifiedlivevirusvaccinewithachlamydialcomponent

Ejemplares similares